Thomas Klingebiel
Impact in
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Hematology 129
- Hematopoietic Stem Cell Transplantation 105
- Acute Myeloid Leukemia Research 27
- Immunology 82
- Immune Cell Function and Interaction 64
- T-cell and B-cell Immunology 28
- Co-authors
- Peter BaderRupert HandgretingerD. NiethammerThomas LehrnbecherUlrike KoehlHermann KreyenbergPeter LangGünter Henze
- Journals
- Blood (30 papers)Bone Marrow Transplantation (28 papers)Pediatric Blood & Cancer (23 papers)Journal of Clinical Oncology (14 papers)Biology of Blood and Marrow Transplantation (11 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Thomas Klingebiel
297 papers receiving 9.8k citations
Peers
Comparison fields: 5 of 160
- Hematology 4.3k
- Immunology 2.6k
- Oncology 3.1k
- Public Health, Environmental and Occupational Health 2.4k
- Neurology 1.0k
Countries citing papers authored by Thomas Klingebiel
This map shows the geographic impact of Thomas Klingebiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Klingebiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Klingebiel more than expected).
Fields of papers citing papers by Thomas Klingebiel
This network shows the impact of papers produced by Thomas Klingebiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Klingebiel. The network helps show where Thomas Klingebiel may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Klingebiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 13 | |
| 3 | 2022 | 11 | |
| 4 | 2021 | 4 | |
| 5 | 2018 | 10 | |
| 6 | 2018 | 32 | |
| 7 | 2016 | 37 | |
| 8 | 2016 | 60 | |
| 9 | 2013 | 123 | |
| 10 | 2010 | 197 | |
| 11 | SURVIVAL AFTER RECURRENCE OF METASTATIC RHAFIDOMYOSARCOMA - AN UNPROBABLE, BUT NOT IMPOSSIBLE EVENT IN THE EXPERIENCE OF THE COOPERATIVE WEICHTEILSARKOM STUDIENGRUPPE (CWS) | 2010 | 1 |
| 12 | 2008 | 252 | |
| 13 | 2007 | 21 | |
| 14 | 2005 | 58 | |
| 15 | Immunosuppressive therapy for children with refractory anemia | 2003 | 1 |
| 16 | 2003 | 5 | |
| 17 | Abwehrprozesse als Adaptationsleistung | 1997 | 2 |
| 18 | 1997 | 37 | |
| 19 | Which children do benefit from bone marrow transplant | 1996 | 4 |
| 20 | 1995 | 13 |
About Thomas Klingebiel
Thomas Klingebiel is a scholar working on Hematology, Immunology, Oncology, Transplantation and Public Health, Environmental and Occupational Health, having authored 305 papers that have together received 10.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (105 papers), Immune Cell Function and Interaction (64 papers), Acute Lymphoblastic Leukemia research (57 papers), Sarcoma Diagnosis and Treatment (41 papers), CAR-T cell therapy research (36 papers), Neuroblastoma Research and Treatments (30 papers), T-cell and B-cell Immunology (28 papers) and Acute Myeloid Leukemia Research (27 papers). The work is most often cited by research in Hematology (4.3k citations), Immunology (2.6k citations), Oncology (3.1k citations), Public Health, Environmental and Occupational Health (2.4k citations) and Neurology (1.0k citations). Thomas Klingebiel has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Peter Bader, Rupert Handgretinger, D. Niethammer, Thomas Lehrnbecher, Ulrike Koehl, Hermann Kreyenberg, Peter Lang, Günter Henze, Arend von Stackelberg and Martin Schrappe. Their work appears in journals such as Blood, Bone Marrow Transplantation, Pediatric Blood & Cancer, Journal of Clinical Oncology and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.